Cancer control and prevention: nutrition and epigenetics

Purpose of reviewTo evaluate recent developments in nutritional epigenomics and related challenges, opportunities, and implications for cancer control and prevention. Recent findingsCancer is one of the leading causes of death worldwide, and understanding the factors that contribute to cancer development may facilitate the development of strategies for cancer prevention and control. Cancer development involves genetic and epigenetic alterations. Genetic marks are permanent, whereas epigenetic marks are dynamic, change with age, and are influenced by the external environment. Thus, epigenetics provides a link between the environment, diet, and cancer development. Proper food selection is imperative for better health and to avoid cancer and other diseases. Nutrients either contribute directly to cancer prevention or support the repair of genomic and epigenomic damage caused by exposure to cancer-causing agents such as toxins, free radicals, radiation, and infectious agents. Nutritional epigenomics provides an opportunity for cancer prevention because selected nutrients have the potential to reverse cancer-associated epigenetic marks in different tumor types. A number of natural foods and their bioactive components have been shown to have methylation-inhibitory and deacetylation-inhibitory properties. SummaryNatural foods and bioactive food components have characteristics and functions that are similar to epigenetic inhibitors and therefore have potential in cancer control and prevention.

[1]  Zhe Zhang,et al.  Endothelin Receptor Type B Gene Promoter Hypermethylation in Salivary Rinses Is Independently Associated with Risk of Oral Cavity Cancer and Premalignancy , 2010, Cancer Prevention Research.

[2]  Melissa C. Greven,et al.  Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women , 2010, Epigenetics.

[3]  David E. Williams,et al.  Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells , 2011, Clinical Epigenetics.

[4]  M. Pertile,et al.  Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. , 2008, Cancer letters.

[5]  S. Ross,et al.  Targeting the Epigenome with Bioactive Food Components for Cancer Prevention , 2012, Lifestyle Genomics.

[6]  F. Feng,et al.  Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence , 2010, Clinical Cancer Research.

[7]  Hong Wang,et al.  Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α. , 2011, Carcinogenesis.

[8]  R. Sandler,et al.  Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer , 2010, Cancer Causes & Control.

[9]  L. Trasande,et al.  Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. , 2012, JAMA.

[10]  M. Osterheld,et al.  Imprinting of tumor-suppressor genes in human placenta , 2009, Epigenetics.

[11]  L. Watson,et al.  Colorectal Cancer Protective Effects and the Dietary Micronutrients Folate, Methionine, Vitamins B6, B12, C, E, Selenium, and Lycopene , 2006, Nutrition and cancer.

[12]  C. Klein,et al.  Modulation of gene methylation by genistein or lycopene in breast cancer cells , 2008, Environmental and molecular mutagenesis.

[13]  E. Ho,et al.  Dietary agents as histone deacetylase inhibitors , 2006, Molecular carcinogenesis.

[14]  K. Kiura,et al.  Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma , 2012, Cancer science.

[15]  Jungang Lv,et al.  Dietary exposure estimates of 16 polycyclic aromatic hydrocarbons (PAHs) in Xuanwei and Fuyuan, counties in a high lung cancer incidence area in China. , 2012, Journal of environmental monitoring : JEM.

[16]  G. Kristiansen,et al.  Histone methylation defines an epigenetic entity in penile squamous cell carcinoma. , 2013, The Journal of urology.

[17]  D. Pookot,et al.  Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function , 2008, Molecular Cancer Therapeutics.

[18]  Dirk Schadendorf,et al.  Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. , 2011, Carcinogenesis.

[19]  Wim Van Criekinge,et al.  Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. , 2013, The Journal of urology.

[20]  Ke-Zhi Wang,et al.  Preparation, characterization, and photoelectric properties of an electrostatically self-assembled film based on tungstophosphoric acid and a binuclear Ru(II) complex. , 2011, Journal of nanoscience and nanotechnology.

[21]  Carsten Wiuf,et al.  Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers , 2011, Clinical Cancer Research.

[22]  D. Romagnolo,et al.  Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. , 2010, The Journal of nutrition.

[23]  L. J. Su,et al.  Diet, epigenetics, and cancer. , 2012, Methods in molecular biology.

[24]  C. Gerhäuser.  Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges , 2012 .

[25]  T. Tollefsbol,et al.  Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. , 2010, Current medicinal chemistry.

[26]  C. Davis,et al.  Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer. , 2010, Seminars in oncology.

[27]  D. Silverman,et al.  Correlation of LINE-1 Methylation Levels in Patient-Matched Buffy Coat, Serum, Buccal Cell, and Bladder Tumor Tissue DNA Samples , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[28]  Guido Marcucci,et al.  Curcumin is a potent DNA hypomethylation agent. , 2009, Bioorganic & medicinal chemistry letters.

[29]  M. Banqué,et al.  Food Groups and Nutrient Intake and Risk of Colorectal Cancer: A Hospital-Based Case-Control Study in Spain , 2012, Nutrition and cancer.

[30]  A. Kong,et al.  A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics. , 2013, Topics in current chemistry.

[31]  A. Gabory,et al.  Conference on ‘ Over-and undernutrition : challenges and approaches ’ Symposium 2 : Modern approaches to nutritional research challenges Nutritional developmental epigenomics : immediate and long-lasting effects , 2010 .

[32]  Yair Lotan,et al.  Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[33]  M. Esteller.  Cancer, epigenetics and the Nobel Prizes , 2012, Molecular oncology.

[34]  The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment. , 2009, Carcinogenesis.

[35]  Zengtong Zhou,et al.  DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients , 2012, Medical Oncology.

[36]  Xinran Xu,et al.  Diet, epigenetic, and cancer prevention. , 2010, Advances in genetics.

[37]  V. Theodorou,et al.  Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancer , 2011, The EMBO journal.

[38]  E. Ho,et al.  Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. , 2011, Molecular nutrition & food research.

[39]  J. Issa,et al.  Epigenetics in cancer: what's the future? , 2011, Oncology.

[40]  Y. Bao,et al.  Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention , 2012, Proceedings of the Nutrition Society.

[41]  Fajun Yang,et al.  Design, synthesis and biological study of pinacolyl boronate-substituted stilbenes as novel lipogenic inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[42]  P. Snijders,et al.  Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer , 2012, Journal of Clinical Pathology.

[43]  A. Wolffe,et al.  Inheritance of chromatin states. , 1994, Developmental genetics.

[44]  A. Madan,et al.  Epigenetic regulation of maspin expression in the human placenta. , 2006, Molecular human reproduction.

[45]  Michael O. Kelleher,et al.  The cancer chemopreventive actions of phytochemicals derived from glucosinolates , 2008, European journal of nutrition.

[46]  M. Verma.  Cancer control and prevention by nutrition and epigenetic approaches. , 2012, Antioxidants & redox signaling.

[47]  S. Lelièvre,et al.  Redefining the impact of nutrition on breast cancer incidence: is epigenetics involved? , 2012, Nutrition Research Reviews.

[48]  J. Lee,et al.  Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens. , 2012, Analytical and quantitative cytopathology and histopathology.

[49]  D. Anderton,et al.  Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy , 2011, Epigenetics.

[50]  R. Mishra,et al.  Epigenetic regulation of genes during development: a conserved theme from flies to mammals. , 2008, Journal of genetics and genomics = Yi chuan xue bao.

[51]  P. Vos,et al.  Transcriptomic molecular markers for screening human colon cancer in stool and tissue. , 2007, Cancer genomics & proteomics.

[52]  U. Lim,et al.  Dietary and lifestyle factors of DNA methylation. , 2012, Methods in molecular biology.

[53]  C. Plass,et al.  Cancer chemoprevention by targeting the epigenome. , 2011, Current drug targets.

[54]  L. Gudas,et al.  Epigenetic Regulatory Mechanisms Distinguish Retinoic Acid-mediated Transcriptional Responses in Stem Cells and Fibroblasts* , 2010, The Journal of Biological Chemistry.

[55]  B. Aggarwal,et al.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. , 2011, Current drug targets.

[56]  C. Davis,et al.  MicroRNA, nutrition, and cancer prevention. , 2011, Advances in nutrition.

[57]  C. Hiley,et al.  Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines , 2011, Cancer Chemotherapy and Pharmacology.

[58]  B. Zhu,et al.  Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. , 2006, Carcinogenesis.

[59]  C. Davis,et al.  Molecular targets for nutritional preemption of cancer. , 2007, Current cancer drug targets.

[60]  M. Gariboldi,et al.  miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation , 2012, Molecular Cancer Research.

[61]  M. Fang,et al.  Dietary polyphenols may affect DNA methylation. , 2007, The Journal of nutrition.

[62]  L. Påhlman,et al.  Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa , 2011, BMC Cancer.

[63]  L. van Neste,et al.  Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis , 2010, Oncogene.

[64]  T. Byers,et al.  Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. , 2010, Cancer research.

[65]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  B. Ganesh,et al.  A case-control study of risk factors for lung cancer in Mumbai, India. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[67]  I. Louro,et al.  Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma , 2011, Molecular Biology Reports.

[68]  Sang-Woon Choi,et al.  Epigenetics: A New Bridge between Nutrition and Health. , 2010, Advances in nutrition.

[69]  Gillian Mitchell,et al.  Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[70]  M. Wargovich,et al.  Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer. , 2012, Anti-cancer agents in medicinal chemistry.

[71]  T. Okai,et al.  A case of pancreatic cancer with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility of diagnosis by hypermethylation of pure pancreatic juice. , 2008, JOP : Journal of the pancreas.

[72]  W. Dai,et al.  De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. , 2008, International journal of oncology.

[73]  R. Eeles,et al.  Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls , 2007, Breast Cancer Research.

[74]  M. Pallàs,et al.  Modulation of sirtuins: new targets for antiageing. , 2008, Recent patents on CNS drug discovery.

[75]  S. Land,et al.  DNA/RNA markers for colorectal cancer risk in preserved stool specimens: a pilot study. , 2009, Tumori.

[76]  A. Zekri,et al.  MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[77]  L. Walker,et al.  Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. , 2012, Chemical research in toxicology.

[78]  P. Denev,et al.  Inhibition of lung tumor development by berry extracts in mice exposed to cigarette smoke , 2012, International journal of cancer.

[79]  Joo Song Lim,et al.  All-trans retinoic acid induces cellular senescence by up-regulating levels of p16 and p21 via promoter hypomethylation. , 2011, Biochemical and biophysical research communications.

[80]  K. Lillycrop,et al.  Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. , 2010, Annual review of nutrition.

[81]  Taichi E. Takasuka,et al.  Proliferating Cell Nuclear Antigen (PCNA) Is Required for Cell Cycle-regulated Silent Chromatin on Replicated and Nonreplicated Genes* , 2010, The Journal of Biological Chemistry.

[82]  E. Ho,et al.  Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? , 2006, Carcinogenesis.

[83]  Jeremy MG Taylor,et al.  Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas , 2012, Epigenetics.

[84]  H. Hayatsu.  Re: Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. , 2010, Journal of the National Cancer Institute.

[85]  H. Dombret,et al.  Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome , 2010, Oncotarget.

[86]  M. Copetti,et al.  Aberrant promoter methylation of beta‐1,4 galactosyltransferase 1 as potential cancer‐specific biomarker of colorectal tumors , 2012, Genes, chromosomes & cancer.

[87]  J. Savickienė,et al.  Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells , 2011, Molecular and Cellular Biochemistry.

[88]  M. Kang,et al.  Dietary rice bran component γ-oryzanol inhibits tumor growth in tumor-bearing mice. , 2012, Molecular nutrition & food research.

[89]  A. Kyritsis,et al.  Modulation of Glioma Risk and Progression by Dietary Nutrients and Antiinflammatory Agents , 2011, Nutrition and cancer.

[90]  J. Califano,et al.  Promoter hypermethylation in Indian primary oral squamous cell carcinoma , 2010, International journal of cancer.

[91]  S. Katiyar,et al.  (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. , 2011, Carcinogenesis.

[92]  V. Sica,et al.  Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities. , 2007, The international journal of biochemistry & cell biology.

[93]  H. Karlic,et al.  Epigenetic mechanisms in anti‐cancer actions of bioactive food components – the implications in cancer prevention , 2012, British journal of pharmacology.

[94]  W. Vanden Berghe.  Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. , 2012, Pharmacological research.

[95]  Yong Wang,et al.  Nanopore-based detection of circulating microRNAs in lung cancer patients , 2011, Nature nanotechnology.

[96]  S. Gelmini,et al.  Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers , 2011, Clinical chemistry and laboratory medicine.

[97]  M. Verma,et al.  Epigenetics of colon cancer. , 2012, Methods in molecular biology.

[98]  R. Dahiya,et al.  BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. , 2009, Carcinogenesis.

[99]  S. Pastorino,et al.  MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. , 2012, Neuro-oncology.

[100]  K. Ohtsubo,et al.  Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma , 2006, Journal of Gastroenterology.

[101]  E. Ho,et al.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. , 2006, Carcinogenesis.

[102]  R. Zhao,et al.  Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. , 2008, Carcinogenesis.

[103]  D. Carpenter,et al.  Levels of Polychlorinated Biphenyls (PCBs) and Three Organochlorine Pesticides in Fish from the Aleutian Islands of Alaska , 2010, PloS one.

[104]  R. Burk,et al.  Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. , 2011, Gynecologic oncology.

[105]  N. Jakubowski,et al.  Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids. , 2010, Bioanalysis.

[106]  N. Matsubara,et al.  Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. , 2009, Journal of the National Cancer Institute.

[107]  Zigang Dong,et al.  Molecular targets of phytochemicals for cancer prevention , 2011, Nature Reviews Cancer.

[108]  V. Tsatsaris,et al.  Comparative Methylation of ERVWE1/Syncytin-1 and Other Human Endogenous Retrovirus LTRs in Placenta Tissues , 2009, DNA research : an international journal for rapid publication of reports on genes and genomes.

[109]  J. Thomas-Ahner,et al.  Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: characterization, metabolism, and interconversion. , 2012, Molecular nutrition & food research.

[110]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  F. Graziano,et al.  Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[112]  D. W. Knowles,et al.  NuMA influences higher order chromatin organization in human mammary epithelium. , 2006, Molecular biology of the cell.

[113]  E. Ho,et al.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice , 2006 .

[114]  A. Chinnaiyan,et al.  Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma , 2012, Oncotarget.

[115]  P. Negraes,et al.  DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection , 2008, BMC Cancer.

[116]  L. Ferguson,et al.  Selenium and its' role in the maintenance of genomic stability. , 2012, Mutation research.

[117]  A. Goel,et al.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. , 2010, Biochemical pharmacology.

[118]  R. Dashwood,et al.  Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. , 2006, Current drug targets.

[119]  T. Liloglou,et al.  DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer. , 2012, Cancer research.

[120]  M. Verma.  Epigenetic biomarkers in cancer epidemiology. , 2012, Methods in molecular biology.

[121]  K. Lillycrop,et al.  Epigenetics: are there implications for personalised nutrition? , 2012, Current opinion in clinical nutrition and metabolic care.

[122]  R. Sinha,et al.  Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. , 2012, The American journal of clinical nutrition.

[123]  David E. Williams,et al.  Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly , 2011, Molecular Cancer.

[124]  M. Recio,et al.  Cocoa Polyphenols and Their Potential Benefits for Human Health , 2012, Oxidative medicine and cellular longevity.

[125]  P. Dekhuijzen,et al.  Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy. , 2012, Chest.

[126]  J. Saunders,et al.  Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers , 2011, Cancer Prevention Research.

[127]  A. Fernández-Villar,et al.  Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma , 2012, Cancer biology & therapy.

[128]  M. Esteller.  Cancer Epigenetics for the 21st Century: What's Next? , 2011, Genes & cancer.

[129]  H. Ditzel,et al.  Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study , 2012, PloS one.

[130]  Tabitha M. Hardy,et al.  Epigenetic diet: impact on the epigenome and cancer. , 2011, Epigenomics.

[131]  David E. Williams,et al.  Dietary factors and epigenetic regulation for prostate cancer prevention. , 2011, Advances in nutrition.

[132]  M. Lea,et al.  Induction of histone acetylation in rat liver and hepatoma by organosulfur compounds including diallyl disulfide. , 2001, Anticancer research.